Physician profile
Gregory Daniel Hester
NPI 1508952870
$13,404.25
in general payments reported to CMS, 2019-2025
51 companies · $7,224 in 2025
The $7,224 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2020: $1,096 · 2021: $446 · 2022: $704 · 2023: $1,554 · 2024: $1,895 · 2025: $7,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,530 · Long Term Medical Supply Or Device Loan: $5,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,529.68 |
| Long Term Medical Supply Or Device Loan | $5,142.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hmu Consumables, LLC | $5,142.85 | 2025 | Dornier Medtech |
| Neotract INC. | $935.83 | 2019-2020 | |
| Astellas Pharma US INC | $888.03 | 2019-2025 | Xtandi, Myrbetriq, Padcev |
| Boston Scientific Corporation | $869.86 | 2019-2025 | Spaceoar Vue System - 10ml, Spaceoar System, Rezum Generator |
| Medtronic, INC. | $697.65 | 2023-2025 | Interstim |
| Pfizer INC. | $372.37 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $299.27 | 2019-2023 | Aveed, Xiaflex |
| Ferring Pharmaceuticals INC. | $284.28 | 2019-2024 | Adstiladrin |
| Janssen Biotech, INC. | $262.08 | 2023-2025 | Erleada |
| Sumitomo Pharma America, INC. | $255.05 | 2023-2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $241.29 | 2022-2024 | Aquabeam System, Aquabeam Robotic System |
| Abbvie INC. | $190.05 | 2019-2025 | |
| C. R. Bard, INC. & Subsidiaries | $173.42 | 2023-2024 | Bard Urinary Drainage Bag |
| Merck Sharp & Dohme LLC | $166.84 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Myriad Genetic Laboratories, INC. | $154.49 | 2023-2025 | Prolaris |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $152.16 | 2022-2025 | Cure Ultra Catheter, Cure Catheter |
| Progenics Pharmaceuticals, INC. | $148.39 | 2023-2025 | Pylarify |
| Immunitybio, INC. | $141.30 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $132.45 | 2024-2025 | Provenge |
| Urogen Pharma, INC. | $131.28 | 2023-2025 | Jelmyto |
| Astrazeneca Pharmaceuticals LP | $123.73 | 2021 | |
| Tolmar, INC. | $101.57 | 2023-2025 | Jatenzo, Eligard |
| Azurity Pharmaceuticals, INC. | $101.19 | 2025 | Azmiro |
| Olympus America INC. | $90.39 | 2024-2025 | Itind System |
| Tolmar Pharmaceuticals, INC. | $87.47 | 2021 | |
| Verity Pharmaceuticals INC. | $87.37 | 2024-2025 | Trelstar, Tlando |
| Antares Pharma, INC. | $86.84 | 2020-2025 | Xyosted |
| Convatec INC. | $85.83 | 2023 | |
| Bluewind Medical | $83.95 | 2025 | Revi |
| Teleflex LLC | $83.94 | 2022-2025 | Barrigel |
| Ambu INC. | $74.88 | 2021-2024 | |
| Alnylam Pharmaceuticals INC. | $64.71 | 2022-2023 | Oxlumo |
| Halozyme INC | $58.44 | 2023 | |
| Novartis Pharmaceuticals Corporation | $57.35 | 2025 | |
| Laborie Medical Technologies Corp. | $56.74 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Endo USA, INC. | $55.19 | 2025 | Aveed, Xiaflex |
| Novo Nordisk INC | $53.58 | 2024 | Rivfloza |
| Healthtronics Stone Solutions, LLC | $48.54 | 2024 | Dornier Medtech |
| Amgen INC. | $46.61 | 2023 | Xgeva |
| Bayer Healthcare Pharmaceuticals INC. | $43.92 | 2022-2025 | |
| Accord Healthcare, INC. | $40.96 | 2023-2024 | |
| Axonics, INC. | $35.16 | 2023 | Axonics |
| Blue Earth Diagnostics | $26.80 | 2025 | Posluma |
| Urovant Sciences INC | $25.80 | 2021 | |
| Medtronic USA, INC. | $25.37 | 2019 | |
| Tempus Ai, INC | $23.24 | 2024 | |
| Abc Home Medical Supply, INC. | $22.78 | 2022 | |
| Biotissue Holdings INC. | $21.34 | 2022 | |
| Coloplast Corp | $18.53 | 2022 | |
| Telix Pharmaceuticals | $17.06 | 2023 | Illuccix |
| Profound Medical Corp. | $16.03 | 2025 | Tulsa-Pro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$14,814.84 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Hester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.